Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Meiraz A et al. – The results show that as the immune response progresses in vivo, targeted cellular suicide mainly prunes high perforin–expressing CD8+ cells, resulting in the gradual switch in effector CTL, from mostly perforin–based to largely Fas/FasL–based killers. Hence, two kinds of CD8+ CTL have two killing strategies.

Related Articles

Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells?
Arthritis Research & Therapy, 10/14/09    Relevance Score: 81%

Induction of granulysin in CD8+ T cells by IL-21 and IL-15 is suppressed by human immunodeficiency virus-1
Journal of Leukocyte Biology, 11/09/09    Relevance Score: 80%

Zeta chain expression in T and NK cells in peripheral blood of children with nephrotic syndrome
Pediatric Nephrology, 10/28/09    Relevance Score: 79%

Role of CD8+ T-cell immunity in influenza infection: potential use in future vaccine development
Expert Review of Respiratory Medicine, 10/14/09    Relevance Score: 79%

Measurement of cytotoxic T lymphocyte activity of human cytomegalovirus seropositive individuals by a highly sensitive coupled luminescent method
Medical Microbiology and Immunology, 10/13/09    Relevance Score: 79%

Today in Hematology/Oncology...keeping you current

Prioritization of cancer antigens: keeping the target in sight
Expert Review of Vaccines, 12/02/09

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Clinical Cancer Research, 12/01/09

A High-Affinity Fully Human Anti–IL-6 mAb, 1339, for the Treatment of Multiple Myeloma
Clinical Cancer Research, 12/01/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address